American Heart Association Vascular Disease Strategically Focused Research Network

Joey V. Barnett; Joshua A. Beckman; Marc P. Bonaca; Mercedes R. Carnethon; Lisa A. Cassis; Mark A. Creager; Alan Daugherty; Mark W. Feinberg; Matthew S. Freiberg; Philip P. Goodney; Philip Greenland; Christiaan Leeuwenburgh; Scott A. Lemaire; Mary M. McDermott; Marc S. Sabatine; Ying H. Shen; David H. Wasserman; Nancy R. Webb; Quinn S. Wells

doi:10.1161/ATVBAHA.120.313967

American Heart Association Vascular Disease Strategically Focused Research Network

Joey V. Barnett
, Joshua A. Beckman
, Marc P. Bonaca
, Mercedes R. Carnethon
, Lisa A. Cassis
, Mark A. Creager
, Alan Daugherty
, Mark W. Feinberg
, Matthew S. Freiberg
, Philip P. Goodney
, Philip Greenland
, Christiaan Leeuwenburgh
, Scott A. Lemaire
, Mary M. McDermott
, Marc S. Sabatine
, Ying H. Shen
, David H. Wasserman
, Nancy R. Webb
, Quinn S. Wells

Producción científica: Review article › revisión exhaustiva

1 Cita (Scopus)

Resumen

The SFRN funding mechanism is designed to facilitate multidisciplinary and collaborative approaches to advance basic research, detection, and therapy of strategic areas that are consistent with the AHA mission to be a relentless force for a world of longer, healthier lives. In this context, the Vascular Disease SFRN focuses on PAD and aortopathies that have a major impact on public health, while also having major unmet needs regarding medical therapy. In addition to the funding provided for projects within the 4 years of support, this SFRN will form a legacy by training a cadre of postdoctoral fellows that will continue to develop research careers and provide further insights into mechanisms of PAD and aortic diseases.

Idioma original	English
Páginas (desde-hasta)	E47-E54
Publicación	Arteriosclerosis, Thrombosis, and Vascular Biology
Volumen	40
N.º	3
DOI	https://doi.org/10.1161/ATVBAHA.120.313967
Estado	Published - mar 1 2020

Nota bibliográfica

Funding Information:
The authors are supported by the following Strategically Focused Research Network grants from the American Heart Association: 18SFRN33900085 to M.P. Bonaca, M.A. Creager, P.P. Goodney, M.W. Feinberg, and M.S. Sabatine; 18SFRN33900097 to M.M. McDermott, M.R. Carnethon, C. Leeuwenburgh, and P. Greenland; 18SFRN33900001 to A. Daugherty, N.R. Webb, L.A. Cassis, S.A. LeMaire, and Y.H. Shen; 18SFRN33960373 to J.A. Beckman, J.V. Barnett, D.H. Wasserman, M.S. Freiberg, and Q.S. Wells.

Financiación

The authors are supported by the following Strategically Focused Research Network grants from the American Heart Association: 18SFRN33900085 to M.P. Bonaca, M.A. Creager, P.P. Goodney, M.W. Feinberg, and M.S. Sabatine; 18SFRN33900097 to M.M. McDermott, M.R. Carnethon, C. Leeuwenburgh, and P. Greenland; 18SFRN33900001 to A. Daugherty, N.R. Webb, L.A. Cassis, S.A. LeMaire, and Y.H. Shen; 18SFRN33960373 to J.A. Beckman, J.V. Barnett, D.H. Wasserman, M.S. Freiberg, and Q.S. Wells.

Financiadores	Número del financiador
National Heart, Lung, and Blood Institute (NHLBI)	R01HL133723
National Heart, Lung, and Blood Institute (NHLBI)
American the American Heart Association	18SFRN33900001, 18SFRN33900097, 18SFRN33900085, 18SFRN33960373
American the American Heart Association

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Good health and well being

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Acceder al documento

10.1161/ATVBAHA.120.313967

Otros archivos y enlaces

Citar esto

Barnett, J. V., Beckman, J. A., Bonaca, M. P., Carnethon, M. R., Cassis, L. A., Creager, M. A., Daugherty, A., Feinberg, M. W., Freiberg, M. S., Goodney, P. P., Greenland, P., Leeuwenburgh, C., Lemaire, S. A., McDermott, M. M., Sabatine, M. S., Shen, Y. H., Wasserman, D. H., Webb, N. R., & Wells, Q. S. (2020). American Heart Association Vascular Disease Strategically Focused Research Network. Arteriosclerosis, Thrombosis, and Vascular Biology, 40(3), E47-E54. https://doi.org/10.1161/ATVBAHA.120.313967

@article{3986fe60c5b54cf19fb109d79531e360,

title = "American Heart Association Vascular Disease Strategically Focused Research Network",

abstract = "The SFRN funding mechanism is designed to facilitate multidisciplinary and collaborative approaches to advance basic research, detection, and therapy of strategic areas that are consistent with the AHA mission to be a relentless force for a world of longer, healthier lives. In this context, the Vascular Disease SFRN focuses on PAD and aortopathies that have a major impact on public health, while also having major unmet needs regarding medical therapy. In addition to the funding provided for projects within the 4 years of support, this SFRN will form a legacy by training a cadre of postdoctoral fellows that will continue to develop research careers and provide further insights into mechanisms of PAD and aortic diseases.",

keywords = "United States, aneurysm, diabetes mellitus, peripheral artery disease, public health",

author = "Barnett, \{Joey V.\} and Beckman, \{Joshua A.\} and Bonaca, \{Marc P.\} and Carnethon, \{Mercedes R.\} and Cassis, \{Lisa A.\} and Creager, \{Mark A.\} and Alan Daugherty and Feinberg, \{Mark W.\} and Freiberg, \{Matthew S.\} and Goodney, \{Philip P.\} and Philip Greenland and Christiaan Leeuwenburgh and Lemaire, \{Scott A.\} and McDermott, \{Mary M.\} and Sabatine, \{Marc S.\} and Shen, \{Ying H.\} and Wasserman, \{David H.\} and Webb, \{Nancy R.\} and Wells, \{Quinn S.\}",

note = "Funding Information: The authors are supported by the following Strategically Focused Research Network grants from the American Heart Association: 18SFRN33900085 to M.P. Bonaca, M.A. Creager, P.P. Goodney, M.W. Feinberg, and M.S. Sabatine; 18SFRN33900097 to M.M. McDermott, M.R. Carnethon, C. Leeuwenburgh, and P. Greenland; 18SFRN33900001 to A. Daugherty, N.R. Webb, L.A. Cassis, S.A. LeMaire, and Y.H. Shen; 18SFRN33960373 to J.A. Beckman, J.V. Barnett, D.H. Wasserman, M.S. Freiberg, and Q.S. Wells.",

year = "2020",

month = mar,

day = "1",

doi = "10.1161/ATVBAHA.120.313967",

language = "English",

volume = "40",

pages = "E47--E54",

number = "3",

}

Barnett, JV, Beckman, JA, Bonaca, MP, Carnethon, MR, Cassis, LA, Creager, MA, Daugherty, A, Feinberg, MW, Freiberg, MS, Goodney, PP, Greenland, P, Leeuwenburgh, C, Lemaire, SA, McDermott, MM, Sabatine, MS, Shen, YH, Wasserman, DH, Webb, NR & Wells, QS 2020, 'American Heart Association Vascular Disease Strategically Focused Research Network', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 40, n.º 3, pp. E47-E54. https://doi.org/10.1161/ATVBAHA.120.313967

TY - JOUR

T1 - American Heart Association Vascular Disease Strategically Focused Research Network

AU - Barnett, Joey V.

AU - Beckman, Joshua A.

AU - Bonaca, Marc P.

AU - Carnethon, Mercedes R.

AU - Cassis, Lisa A.

AU - Creager, Mark A.

AU - Daugherty, Alan

AU - Feinberg, Mark W.

AU - Freiberg, Matthew S.

AU - Goodney, Philip P.

AU - Greenland, Philip

AU - Leeuwenburgh, Christiaan

AU - Lemaire, Scott A.

AU - McDermott, Mary M.

AU - Sabatine, Marc S.

AU - Shen, Ying H.

AU - Wasserman, David H.

AU - Webb, Nancy R.

AU - Wells, Quinn S.

N1 - Funding Information: The authors are supported by the following Strategically Focused Research Network grants from the American Heart Association: 18SFRN33900085 to M.P. Bonaca, M.A. Creager, P.P. Goodney, M.W. Feinberg, and M.S. Sabatine; 18SFRN33900097 to M.M. McDermott, M.R. Carnethon, C. Leeuwenburgh, and P. Greenland; 18SFRN33900001 to A. Daugherty, N.R. Webb, L.A. Cassis, S.A. LeMaire, and Y.H. Shen; 18SFRN33960373 to J.A. Beckman, J.V. Barnett, D.H. Wasserman, M.S. Freiberg, and Q.S. Wells.

PY - 2020/3/1

Y1 - 2020/3/1

N2 - The SFRN funding mechanism is designed to facilitate multidisciplinary and collaborative approaches to advance basic research, detection, and therapy of strategic areas that are consistent with the AHA mission to be a relentless force for a world of longer, healthier lives. In this context, the Vascular Disease SFRN focuses on PAD and aortopathies that have a major impact on public health, while also having major unmet needs regarding medical therapy. In addition to the funding provided for projects within the 4 years of support, this SFRN will form a legacy by training a cadre of postdoctoral fellows that will continue to develop research careers and provide further insights into mechanisms of PAD and aortic diseases.

AB - The SFRN funding mechanism is designed to facilitate multidisciplinary and collaborative approaches to advance basic research, detection, and therapy of strategic areas that are consistent with the AHA mission to be a relentless force for a world of longer, healthier lives. In this context, the Vascular Disease SFRN focuses on PAD and aortopathies that have a major impact on public health, while also having major unmet needs regarding medical therapy. In addition to the funding provided for projects within the 4 years of support, this SFRN will form a legacy by training a cadre of postdoctoral fellows that will continue to develop research careers and provide further insights into mechanisms of PAD and aortic diseases.

KW - United States

KW - aneurysm

KW - diabetes mellitus

KW - peripheral artery disease

KW - public health

UR - https://www.scopus.com/pages/publications/85081161283

UR - https://www.scopus.com/pages/publications/85081161283#tab=citedBy

U2 - 10.1161/ATVBAHA.120.313967

DO - 10.1161/ATVBAHA.120.313967

M3 - Review article

C2 - 31969016

AN - SCOPUS:85081161283

SN - 1079-5642

VL - 40

SP - E47-E54

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

IS - 3

ER -

American Heart Association Vascular Disease Strategically Focused Research Network

Resumen

Nota bibliográfica

Financiación

ODS de las Naciones Unidas

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto